Glycosaminoglycans are complex polysaccharides, which play major biological roles in health and disease, intracellularly, at the cell surface and in the extracellular matrix. The sulfated glycosaminoglycans, namely chondroitin sulfate, dermatan sulfate, heparan sulfate, heparin and keratan sulfate are covalently attached to various protein cores to form proteoglycans [1] . In contrast hyaluronan, a non-sulfated glycosaminoglycan, does not form proteoglycans but mediates the formation of highmolecular-weight proteoglycan aggregates. In this special issue, various aspects of glycosaminoglycans and their biological roles are discussed.
These findings are important for the development of GAGtargeted therapeutic approaches in cancer. The role of heparan sulfate proteoglycans in breast cancer and the use of heparin and nano-heparin formulations with anti-metastatic and antiangiogenic activities as therapeutic tools in breast cancer are reviewed by Afratis et al. Polysaccharides mimicking heparan sulfate, called ReGeneraTing Agents (RGTAs), have been chemically engineered to replace heparan sulfate in injured tissues and facilitate tissue repair, which opens new perspectives in regenerative medicine (Barritault et al.).
Sulfated glycosaminoglycans are attached to core proteins. Heparan sulfate, proteoglycans such as syndecans, glypicans, perlecan, and agrin, which bind to growth factors, chemokines and cytokines, are key regulators of the mesenchymal niche of hematopoietic stem cells and play a role in the interaction of hematopoietic stem cells with their endosteal niche in bone marrow (Papy-Garcia and Albanese). Frey et al. report a novel biological function of the soluble proteoglycan biglycan, which is mediated by its interaction with Toll-like receptor-2. This small leucine-rich proteoglycan promotes the synthesis of erythropoietin, which leads to secondary polycythemia disease characterized by a selective increase in circulating mature erythrocytes.
GAGs are able to bind a variety of proteins and these interactions are mediated and regulated among other things by their sulfation pattern and epimerization. The characterization at the molecular level of GAG-protein interactions is crucial to decipher the molecular mechanisms supporting GAG biological activities and to design inhibitors targeting these interactions. The interactions established by chondroitin sulfate, the most abundant GAG in the central nervous system extracellular matrix, with various protein families involved in physiological and cognitive mechanisms are reviewed by Djerbal et al. et al.) . A mass spectrometry (MS)-based hyphenated method, based on the simultaneous measurement of MS/MS and gas phase IR spectra, has been developed by Schindler et al. to get structural information on GAGs. They report the analysis of hexuronic acid epimers in GAGs using this approach.
19 F labelled glycosaminoglycan probes have been designed for probing GAG-protein interactions by solution nuclear magnetic resonance (NMR) spectroscopy, and they can be imaged using non-linear coherent anti-Stokes Raman scattering (CARS) microscopy (Lima et al.).
The goals of on-going studies are i) to analyze GAG composition and structures (i.e. glycosaminoglycomes) of complex biological samples such as cells, tissues, conditioned cell media and biological fluids, and ii) their interaction repertoires to determine how they regulate physiological and pathological mechanisms at the molecular level. The techniques used to analyze the glycosaminoglycomes (e.g. chromatography, mass spectrometry, NMR and vibrational spectroscopies), the roadmap designed to build GAG interaction networks, the databases storing protein-GAG interaction data and the bioinformatics standards developed to standardize the format of GAG chemical features and sequences are reviewed by Ricard-Blum and Lisacek.
